RxDoctor Payments Data

Daniel Guarderas Paredes, MD

Hospitalist · East Boston, MANPI 1306297411

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 40 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by AstraZeneca at 30.7% of the total. Reporting peaked in 2019 at $330 and has fallen 93.9% since, to $20 in 2025. Among hospitalist clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$613in general payments, 2019–2025

Across 40 payments — averaging $15.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$188
  • E.r. Squibb & Sons, L.L.C.$182
  • Johnson & Johnson$131
  • Viiv Healthcare Company$43
  • Pfizer$26
  • Insmed, Inc.$22
  • plus $20 from 1 others

What the payments were for

  • Food & beverage$613100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$613 in reported general payments places this provider in the 90th percentile of 599 hospitalist providers in Massachusetts.

See all hospitalist providers in Massachusetts

Medicare billing

Part B allowed, 2024
$46,120
Medicare patients
311
Services billed
337

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hospitalist in East Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →